This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
The lowly mushroom, grown quietly, in the dark, has suddenly sprung onto the health scene as a miracle cure. Once castigated as a mere fungus, the mushroom has acquired a signature cachet in the form of active hexose-correlated compound (AHCC), a nutritional product made from healing mushrooms fermented in rice bran. AHCC is used in over 700 clinics and hospitals in Japan, mainly in cancer treatment.Now AHCC: Japan’s Medical Breakthrough in Immunotherapy reveals what the Japanese have known for decades: AHCC is as well researched as any conventional prescription drug. The quality control of AHCC is so stringent that it would easily qualify as a licensed pharmaceutical, but the manufacturers believe that this would limit its availability to the many people in Japan–healthy people, who use it as a preventive as well as for a variety of other purposes. Because it is actually a mushroom-based food, even though it is often made available in capsule form, it is extremely safe for anyone to take, including children, pets, frail elderly people, and patients who have undergone surgery.AHCC: Japan’s Medical Breakthrough in Immunotherapy explores AHCC in depth, explaining:
How it is manufactured How it is used in clinics in Japan and other parts of the world Its safety and efficacy The scientific evidence supporting its striking versatility and profound effectiveness for a wide variety of conditions
AHCC: Japan’s Medical Breakthrough in Immunotherapy will introduce you to AHCC and expand your knowledge of one of the most important food supplements available on the market today.
